3,4-diaminopyridine for the treatment of Lambert–Eaton myasthenic syndrome

Practical aspects of 3,4-diaminopyridine treatment of the Lambert-Eaton myasthenic syndrome

(2010) H. Lundh et al.   ACTA NEUROLOGICA SCANDINAVICA

3,4-Diaminopyridine safety in clinical practice: an observational, retrospective cohort study

(2010) Laurent Flet et al.   JOURNAL OF NEUROLOGY

Efficacy of 3,4-Diaminopyridine and Pyridostigmine in the Treatment of Lambert–Eaton Myasthenic Syndrome: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study

(2009) PW Wirtz et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

3,4-Diaminopyridine is more effective than placebo in a randomized, double-blind, cross-over drug study in LEMS

(2009) Shin J. Oh et al.   MUSCLE & NERVE

Favorable response to rituximab in a patient with anti-VGCC-positive Lambert-Eaton myasthenic syndrome and cerebellar dysfunction

(2009) Hannah L. Pellkofer et al.   MUSCLE & NERVE

Screening for Small-Cell Lung Cancer: A Follow-Up Study of Patients With Lambert-Eaton Myasthenic Syndrome

(2008) Maarten J. Titulaer et al.   JOURNAL OF CLINICAL ONCOLOGY